Research News

New research shows that pooling data across patients can make brain-to-speech computer interfaces faster and easier to deploy

The Duke team will use AI to make drugs more precise to avoid damage to the microbiome

Michael Rubinstein will help lead the Duke-led research center that explores the science of polymer networks: long, repeating molecules found in a broad range of materials and products from trees to tires to plastics.

Amanda Randles's HARVEY platform leverages supercomputing, physics-based simulations,and wearable device data to monitor real-time hemodynamics and spot heart failure early.

Every day, AI tools get more capable, and deployment is outpacing our understanding of what they get wrong. Duke Engineering Dean Jerry Lynch connects with three Duke University experts to break down where that gap is already showing up: in cybersecurity, in the everyday AI tools people use to get advice, and in healthcare.

Sharon Gerecht's laboratory has constructed an in vitro model to study the inner blood–retina barrier.

New data-driven approach could enhance results for the quickly growing $130 billion probiotics and prebiotics industry.

Tatiana Segura's lab has developed an injectable biomaterial that helps transform the cavity left behind after a stroke caused by a blood clot into an environment more supportive of repair.

Delivered more than 24 hours after a stroke in mice, the biomaterial promoted vascular repair, neural remodeling and improved motor performance

BME Professor Charlie Gersbach is one of several researchers worldwide interviewed for an article on using CRISPR to influence gene expression by editing the epigenome with the goal of treating disease.

Sharon Gerecht and her laboratory have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time.

Duke researchers highlight the gaps in federal guidance governing validation of wearable devices